Erosive Hand Osteoarthritis: Recent Advances and Future Treatments.

IF 5.7 2区医学 Q1 RHEUMATOLOGY

Current Rheumatology Reports Pub Date : 2024-04-01 Epub Date: 2024-01-12 DOI:10.1007/s11926-023-01130-9

Marta B Bean, Marta Favero, Roberta Ramonda, Carla R Scanzello

{"title":"Erosive Hand Osteoarthritis: Recent Advances and Future Treatments.","authors":"Marta B Bean, Marta Favero, Roberta Ramonda, Carla R Scanzello","doi":"10.1007/s11926-023-01130-9","DOIUrl":null,"url":null,"abstract":"Purpose of the review: Erosive hand osteoarthritis (EHOA) is an aggressive form of hand osteoarthritis that leads to significant disability, and recent data suggests that it is increasing in prevalence. This review provides an update of our current understanding of epidemiology, genetic associations, biomarkers, pathogenesis, and treatment of EHOA, with particular focus on studies published within the last 5 years.Recent findings: New studies of EHOA have identified new genetic loci associated with disease, including variants in genes involved in inflammation and bone remodeling. Preclinical studies implicate pathways of innate immunity, including some that may be causal in the condition. Recent novel studies showed that inflammatory features identified by ultrasound and MRI are associated with development of erosive lesions over time on conventional radiography. In the future, these imaging modalities may be useful in identifying patients at risk of adverse outcomes. Promising new findings in genetics, biomarkers, and treatment targets will hopefully allow for future therapeutic options for this debilitating condition.","PeriodicalId":10761,"journal":{"name":"Current Rheumatology Reports","volume":" ","pages":"103-111"},"PeriodicalIF":5.7000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10965372/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Rheumatology Reports","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11926-023-01130-9","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/12 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose of the review: Erosive hand osteoarthritis (EHOA) is an aggressive form of hand osteoarthritis that leads to significant disability, and recent data suggests that it is increasing in prevalence. This review provides an update of our current understanding of epidemiology, genetic associations, biomarkers, pathogenesis, and treatment of EHOA, with particular focus on studies published within the last 5 years.

Recent findings: New studies of EHOA have identified new genetic loci associated with disease, including variants in genes involved in inflammation and bone remodeling. Preclinical studies implicate pathways of innate immunity, including some that may be causal in the condition. Recent novel studies showed that inflammatory features identified by ultrasound and MRI are associated with development of erosive lesions over time on conventional radiography. In the future, these imaging modalities may be useful in identifying patients at risk of adverse outcomes. Promising new findings in genetics, biomarkers, and treatment targets will hopefully allow for future therapeutic options for this debilitating condition.

查看原文本刊更多论文

侵蚀性手部骨关节炎：最新进展与未来治疗。

综述的目的：侵蚀性手部骨关节炎（EHOA）是一种侵袭性手部骨关节炎，可导致严重残疾，最近的数据表明其发病率正在上升。本综述介绍了我们目前对 EHOA 的流行病学、遗传关联、生物标志物、发病机制和治疗的最新认识，尤其关注过去 5 年内发表的研究：对 EHOA 的新研究发现了与疾病相关的新基因位点，包括涉及炎症和骨重塑的基因变异。临床前研究发现了先天性免疫的途径，其中一些可能与该病有关。最近的新研究表明，超声波和核磁共振成像发现的炎症特征与传统放射学检查中侵蚀性病变的发展有关。未来，这些成像模式可能有助于识别有不良后果风险的患者。遗传学、生物标志物和治疗靶点方面的新发现有望为这种使人衰弱的疾病提供未来的治疗方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Current Rheumatology Reports RHEUMATOLOGY-

CiteScore

11.20

自引率

0.00%

发文量

期刊介绍： This journal aims to review the most important, recently published research in the field of rheumatology. By providing clear, insightful, balanced contributions by international experts, the journal intends to serve all those involved in the care and prevention of rheumatologic conditions. We accomplish this aim by appointing international authorities to serve as Section Editors in key subject areas such as the many forms of arthritis, osteoporosis and metabolic bone disease, and systemic lupus erythematosus. Section Editors, in turn, select topics for which leading experts contribute comprehensive review articles that emphasize new developments and recently published papers of major importance, highlighted by annotated reference lists. An international Editorial Board reviews the annual table of contents, suggests articles of special interest to their country/region, and ensures that topics are current and include emerging research. Commentaries from well-known figures in the field are also occasionally provided.